Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Sorafenib in Patients With Advanced Renal Cell Carcinoma (MERITS)

This study has been completed.
Sponsor:
Information provided by:
Egyptian Foundation For Cancer Research
ClinicalTrials.gov Identifier:
NCT00848640
First received: February 19, 2009
Last updated: May 25, 2010
Last verified: September 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2010
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)